Hemodialysis market to reach USD 111.8B by 2032

Allied Market Research published a report, titled, “Hemodialysis market by product and service (Equipments, consumables, drugs, and services), type (Conventional hemodialysis, daily hemodialysis, and nocturnal hemodialysis), and dialysis Site (In-center dialysis and home dialysis): Global opportunity analysis and industry forecast, 2023–2032” According to the report, the global hemodialysis industry generated $76.9 billion in 2022 and is anticipated to generate $111.8 billion by 2032, witnessing a CAGR of 3.8% from 2023 to 2032.

Prime determinants of growth
Rise in prevalence of kidney failure and end stage renal disease (ESRD), technological advancement in hemodialysis devices, surge in geriatric population who is vulnerable to kidney failure, and increase in demand for hemodialysis device & services drive the growth of the global hemodialysis market. However, risks and complications associated with dialysis are hampering the hemodialysis market growth. On the contrary, high growth potential in developing countries and increase in R&D regarding hemodialysis products are expected to offer remunerative opportunities for the expansion of the hemodialysis market during the forecast period.

The services segment to maintain its dominance during the forecast period
By type, the services segment held the highest market share in 2022, accounting for nearly two-thirds of the global hemodialysis market revenue and is estimated to maintain its leadership status during the forecast period, owing to the high adoption of hemodialysis services, and the high number of hemodialysis service provider. The consumables segment is projected to attain the highest CAGR of 4.8% from 2023 to 2032, owing to increase in usage of hemodialysis consumables by hemodialysis patients and surge in demand for hemodialysis consumables.

The conventional hemodialysis segment to maintain its dominance during the forecast period
By type, the conventional hemodialysis segment held the highest market share in 2022, accounting for nearly three-fifths of the global hemodialysis market revenue and is estimated to maintain its leadership status during the forecast period, owing to the high adoption of conventional hemodialysis and performed only three days a week, so there is no more risk of other complications. The nocturnal hemodialysis segment is projected to attain the highest CAGR of 4.7% from 2023 to 2032 due to its various advantages such as it is done at night, so patients are free in the day to pursue other activities and improves the health of the patient.

The in-center dialysis segment to maintain its dominance during the forecast period
By dialysis site, the in-center dialysis segment held the highest market share in terms of revenue in 2022, accounting for more than four-fifths of the global hemodialysis market revenue, owing to patient does not require any medical training and majority of hemodialysis devices manufacturing companies are engaged in developing dialysis centers in various regions. The home dialysis segment is expected to witness the fastest CAGR of 5.4% from 2023 to 2032 and is likely to dominate the market during the forecast period, owing to its various advantages such as patient can adjust session schedules in the day or at night by letting the treatment fit around the patient timetables and rise in number of people choice for home dialysis options for dialysis treatment.

North America to maintain its dominance by 2032
Region-wise, North America held the highest market share in terms of revenue in 2022, accounting for more than half of the global hemodialysis market revenue, owing to robust healthcare infrastructure, presence of key players, and rise in healthcare expenditure. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.7% from 2023 to 2032 and is likely to dominate the market during the forecast period, owing to rise in kidney failure cases, unmet medical demands, and high population base.

Leading market players: –

• Asahi Kasei Corporation
• B. Braun Melsungen AG
• Baxter International Inc.
• DaVita Inc.
• Diaverum
• Fresenius Medical Care AG & Co. KGaA
• Nikkiso Co., Ltd
• Nipro Corporation
• Rockwell Medical Technologies Inc.
• TORAY INDUSTRIES, INC. (TORAY MEDICAL CO., LTD.).

The report provides a detailed analysis of these key players in the global hemodialysis market. These players have adopted different strategies such as adopted acquisition, agreement, expansion, merger, partnership, product launch, product approval to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. Allied Market Research